Verano Holdings (VRNO) Exchange Rate Effect (2022 - 2025)
Verano Holdings' (VRNO) quarterly Exchange Rate Effect came in at -$3000.0 in Q4 2025, down 175.0% year-on-year from $4000.0 in Q4 2024, and down 400.0% on a QoQ basis from $1000.0 in Q3 2025.
Verano Holdings (VRNO) Exchange Rate Effect (2022 - 2025) Analysis & Trends
Verano Holdings (VRNO) has 4 years of Exchange Rate Effect data on file, last reported at -$3000.0 in Q4 2025.
- On a quarterly basis, Exchange Rate Effect fell 175.0% year-over-year to -$3000.0 in Q4 2025; TTM through Mar 2026 was -$5000.0, a 266.67% decrease from a year earlier, with the FY2025 full-year figure at -$5000.0, down 127.78% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at -$3000.0, down from $1000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for VRNO reached as high as $103000.0 in Q3 2022 and fell as low as -$111000.0 in Q4 2022.
- Historically, Exchange Rate Effect has averaged $0.0 across 4 years, with a median of -$1000.0 in 2023.
- Across the five-year window, Exchange Rate Effect jumped 1600.0% in 2024 and sank 175.0% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$111000.0 in 2022, then soared by 99.1% to -$1000.0 in 2023, then surged by 500.0% to $4000.0 in 2024, then sank by 175.0% to -$3000.0 in 2025.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$3000.0 in Q4 2025, $1000.0 in Q3 2025, and -$3000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |